Albert Labs International(TSE:ABRT)
CA$0.010.00 (0.00%)
TSE:ABRT
Albert Labs International financials statements
CA$0.01
At close:0.00 (0.00%)
Albert Labs International (ABRT) Ratios
1 Followers
Albert Labs International Ratios
TSE:ABRT's free cash flow for Q3 2023 was C$-10.04K. For the 2023 fiscal year, TSE:ABRT's free cash flow was increased by C$0.00 and operating cash flow was C$-10.04K. See a summary of the company’s cash flow.
| Ratios | Mar 23 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.17 | 0.25 | 9.48 | 0.00 | 0.00 |
| Quick Ratio | 0.17 | 0.25 | 9.48 | 0.00 | 0.00 |
| Cash Ratio | 0.15 | 0.09 | 0.35 | 0.00 | 0.00 |
| Solvency Ratio | -13.34 | -2.18 | 47.17 | 0.02 | -0.23 |
| Operating Cash Flow Ratio | -2.71 | -1.06 | -0.58 | -0.01 | -0.04 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -0.57 | -2282.87 |
| Net Current Asset Value | C$ -437.59K | C$ -642.60K | C$ 260.50K | C$ -1.53M | C$ -1.23M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.17 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.19 | -0.02 | -0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.16 | -0.02 | -0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.45 | -0.71 | 1.12 | 0.00 | -0.00 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.41 | -3.80 | -12178.70 |
| Interest Coverage Ratio | 0.00 | 0.00 | -65.67 | -65.22 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Net Debt to EBITDA | 0.02 | 0.04 | 0.00 | -0.25 | -0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | -310.01% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | -310.01% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -310.01% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -310.01% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -310.01% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -310.01% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 170.59% | 100.00% | 101.52% | 101.53% | 100.00% |
| Return on Assets (ROA) | -4310.49% | -525.16% | -97.53% | 0.00% | -16051.98% |
| Return on Equity (ROE) | 1932.24% | 373.90% | -109.03% | 8.85% | 22.74% |
| Return on Capital Employed (ROCE) | 1132.70% | 373.90% | -107.39% | 8.71% | 22.74% |
| Return on Invested Capital (ROIC) | 1132.70% | 373.90% | -106.74% | 8.91% | 22.74% |
| Return on Tangible Assets | -4310.49% | -525.16% | -97.53% | 0.00% | -16051.98% |
| Earnings Yield | -312.81% | -1181.39% | -111.52% | -53.02% | -109.98% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 606.40 |
| Payables Turnover | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 51.78 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 |
| Cash Conversion Cycle | -22383.50 | -155155.27 | 0.00 | 0.00 | 0.60 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.60 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 22383.50 | 155155.27 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.60 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.23 | -0.00 | -0.00 | -0.01 |
| Free Cash Flow Per Share | -0.03 | -0.27 | -0.00 | -0.00 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -22.29 | -6.42 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -22.29 | -6.42 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -0.35 | -0.57 | -2282.87 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.58 |
| Free Cash Flow Yield | -66.34% | -662.73% | -7.00% | -7.37% | -20.62% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.32 | -0.08 | -0.90 | -1.89 | -0.91 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 2.82 |
| Price-to-Book (P/B) Ratio | -6.18 | -0.32 | 0.98 | -0.17 | -0.21 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.51 | -0.15 | -14.29 | -13.57 | -4.85 |
| Price-to-Operating Cash Flow Ratio | -1.58 | -0.17 | -14.29 | -13.57 | -4.85 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | -0.01 | 0.04 | 0.03 |
| Enterprise Value Multiple | -0.53 | -0.04 | 0.00 | -2.16 | -0.91 |
| Enterprise Value | 2.18M | 82.35K | 294.64K | 287.63K | 254.71K |
| EV to EBITDA | -0.53 | -0.04 | 0.00 | -2.16 | -0.91 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 2.82 |
| EV to Free Cash Flow | -1.45 | -0.08 | -16.53 | -15.32 | -4.85 |
| EV to Operating Cash Flow | -1.52 | -0.09 | -16.53 | -15.32 | -4.85 |
| Tangible Book Value Per Share | -0.01 | -0.13 | 0.04 | -0.24 | -0.19 |
| Shareholders’ Equity Per Share | -0.01 | -0.13 | 0.04 | -0.24 | -0.19 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Income Per Share | -0.13 | -0.47 | -0.04 | -0.02 | -0.04 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.70 | 1.00 | 0.16 | 1.02 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.20 | 0.49 | 0.06 | 0.14 | 0.19 |
Currency in CAD
